Geographic Atrophy

>

Latest News

Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status | Image Credit: Vitreo Retinal Associates
Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status

November 22nd 2024

FDA grants Rare Pediatric Disease, Fast Track designations to gildeuretinol, aiming to accelerate treatment for Stargardt disease.

FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy | Image Credit: US Food and Drug Administration
FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy

November 22nd 2024

Gildeuretinol Shows Promise in Slowing Geographic Atrophy Progression | Image Credit: The Retina Group of Washington
Gildeuretinol Shows Promise in Slowing Geographic Atrophy Progression

October 21st 2024

GALE: Pegcetacoplan Achieves Increasing Efficacy in Subfoveal Geographic Atrophy | Image Credit: California Retina Consultants
GALE: Pegcetacoplan Achieves Increasing Efficacy in Subfoveal Geographic Atrophy

October 21st 2024

ARCHER: ANX007 Mitigates Visual Acuity Loss in Geographic Atrophy| Image Credit: ASRS
ARCHER: ANX007 Mitigates Visual Acuity Loss in Geographic Atrophy

October 19th 2024

<123
© 2024 MJH Life Sciences

All rights reserved.